Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Dissecting the control of transcription elongation

Award Number: R35GM162577
ORGANIZATION: NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 08/01/2026
PERIOD OF PERFORMANCE END DATE: 05/31/2031

Group Awards By:

View Award Description

Dissecting the control of transcription elongation - Project Summary Precise control of gene expression in response to external signals is essential for organismal development, growth, and homeostasis. Accordingly, gene activity is regulated at multiple steps, with tight control over transcription elongation by RNA polymerase II (RNAPII) and the coordinated processing of messenger RNA (mRNA). A critical step in metazoan gene control involves the promoter-proximal pausing of RNAPII and its release into gene bodies. Association of the pause-inducing factors NELF and DSIF with the early elongation complex stabilize RNAPII while awaiting the signal for pause release. Pause release is triggered by the kinase P-TEFb, which phosphorylates RNAPII and DSIF to dissociate NELF and promote productive elongation. However, paused RNAPII can experience an alternate fate: it can be targeted by the Integrator complex (INT), a multi-subunit termination machine. INT drives promoter-proximal termination, with RNAPII releasing a short, unstable RNA. Importantly, we found that INT facilitates termination using two distinct catalytic activities: endonuclease-mediated cleavage of the nascent RNA and phosphatase-dependent removal of stimulatory phosphorylation. In this way, INT prevents spurious transcription and can potently attenuate the expression of select mRNAs. Indeed, the loss of INT causes rapid upregulation of a repertoire of stress- and signal responsive genes. Notably, RNAPII faces further obstacles to elongation across gene bodies. We and others have shown that long genes, especially those with expansive first introns, pose challenges for the transcription machinery, and that a precise interplay between transcription and RNA splicing factors is required for full-length mRNA synthesis. Premature termination within introns produces aberrant transcripts whose export to the cytoplasm can trigger anti-viral immune responses or lead to the translation of deleterious proteins. As such, defects in RNAPII elongation and RNA processing have emerged as key contributors to disease, including inflammatory and neurological disorders and cancer. Over the next five years, my lab will systematically dissect the cis-acting sequences and trans-acting proteins that determine the fate of the elongating RNAPII and nascent RNA, leveraging synergistic cell-free and cell-based systems. We will define the molecular mechanisms and interfaces that control productive elongation and address central questions about how INT activity is regulated. Given the established role of INT in attenuating stress-responsive genes during normal cell growth, we will determine how stress signaling can activate these genes, and how INT deficiency perturbs stress responses. We will build on our finding that association of the U1 small nuclear RNP (snRNP) with RNAPII at 5’ splice sites is a primary determinant of RNAPII processivity, to investigate the mechanisms underlying this activity. Our studies will provide insights into the crosstalk between transcription and RNA processing machines, to illuminate how cells ensure the formation of mature mRNA species, while rapidly terminating spurious transcription.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $165,279 )
2026	2026	PRESIDENT AND FELLOWS OF HARVARD COLLEGE	25 SHATTUCK ST	BOSTON	MA	02115	SUFFOLK	USA	Biomedical Research and Research Training	000	1	6/30/2026	NEW	$165,279
														Subtotal = $165,279

Grand Total All Awards = $165,279

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Dissecting the control of transcription elongation

Award Number: R35GM162577

ORGANIZATION: NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 08/01/2026

PERIOD OF PERFORMANCE END DATE: 05/31/2031

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer